GB1382240A - Method and compositions useful in evaluating bile sufficidncy - Google Patents

Method and compositions useful in evaluating bile sufficidncy

Info

Publication number
GB1382240A
GB1382240A GB5795871A GB5795871A GB1382240A GB 1382240 A GB1382240 A GB 1382240A GB 5795871 A GB5795871 A GB 5795871A GB 5795871 A GB5795871 A GB 5795871A GB 1382240 A GB1382240 A GB 1382240A
Authority
GB
United Kingdom
Prior art keywords
benzoyl
acid
aminobenzoic acid
prepared
tyrosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5795871A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohm and Haas Co
Original Assignee
Rohm and Haas Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohm and Haas Co filed Critical Rohm and Haas Co
Publication of GB1382240A publication Critical patent/GB1382240A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0089—Particulate, powder, adsorbate, bead, sphere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GB5795871A 1970-12-18 1971-12-14 Method and compositions useful in evaluating bile sufficidncy Expired GB1382240A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00099714A US3806592A (en) 1970-12-18 1970-12-18 Method for evaluating bile sufficiency

Publications (1)

Publication Number Publication Date
GB1382240A true GB1382240A (en) 1975-01-29

Family

ID=22276276

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5795871A Expired GB1382240A (en) 1970-12-18 1971-12-14 Method and compositions useful in evaluating bile sufficidncy

Country Status (7)

Country Link
US (1) US3806592A (https=)
BE (1) BE776873A (https=)
CA (1) CA984750A (https=)
DE (1) DE2162745A1 (https=)
FR (1) FR2118178B1 (https=)
GB (1) GB1382240A (https=)
NL (1) NL7117216A (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795418A (fr) * 1972-05-24 1973-08-14 Rohm & Haas Procede d'acylation directe des acides aminobenzoiques
ATE173637T1 (de) * 1990-07-19 1998-12-15 Unicliffe Ltd Diagnostisches mittel zur bestimmung von pankreasinsuffiziens
GB2251381B (en) * 1990-07-19 1995-01-25 Charwell Pharma Emulsified fluorescein diester diagnostic compositions
US5506147A (en) * 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
US6159445A (en) * 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
GB9502065D0 (en) * 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
US6540981B2 (en) 1997-12-04 2003-04-01 Amersham Health As Light imaging contrast agents
US6663846B1 (en) * 1998-12-21 2003-12-16 Mccombs Candace Devices and methods for monitoring drug therapy compliance
WO2018026538A1 (en) * 2016-08-02 2018-02-08 ISI Life Sciences Inc. Novel scaffolds for intracellular compound delivery for the detection of cancer cells
US10239891B2 (en) 2017-05-15 2019-03-26 Indicator Systems International, Inc. Compositions to detect remnant cancer cells
WO2018026965A1 (en) 2016-08-02 2018-02-08 Isi Life Sciences, Inc. Compositions and methods for detecting cancer cells in a tissue sample
US10753942B2 (en) 2017-05-15 2020-08-25 Indicator Systems International, Inc. Methods to detect remnant cancer cells

Also Published As

Publication number Publication date
FR2118178B1 (https=) 1975-08-01
CA984750A (en) 1976-03-02
US3806592A (en) 1974-04-23
DE2162745A1 (de) 1972-06-22
FR2118178A1 (https=) 1972-07-28
NL7117216A (https=) 1972-06-20
BE776873A (fr) 1972-06-19

Similar Documents

Publication Publication Date Title
GB1382240A (en) Method and compositions useful in evaluating bile sufficidncy
GB1496332A (en) Vaccine adjuvants
GB1448810A (en) Fungicidal n-substituted furoic amide derivatives
GB1359123A (en) Preparation of aspartyl amino-acid alkyl esters
GB1453583A (en) Digoxin derivatives
AU5978686A (en) Eicosatriynoic acid esters and amides and their application in pharmaceutical and cosmetic practice
GB1444396A (en) Succinic acid derivatives
GB1343118A (en) Salicylic acid derivatives
GB1526617A (en) 2 and 3-substituted enkephalins
IE34196B1 (en) Improvements in and relating to pepsin inhibitors
GB1158727A (en) Amino Acid Derivatives
GB1298005A (https=)
GB1511804A (en) Cosmetic compositions containing deaminated collagen
GB1481780A (en) Oxathiino-and dithiino-aminoacetic acids and their preparation
GB1469616A (en) Optical resolution of phenyl-glycine amide
ATE42203T1 (de) Semi-synthetisches verfahren zur herstellung von insulin.
GB1440735A (en) Polyethylene terephthalate-containing polymer blends
GB1490290A (en) Preparation of penicillanic acid derivatives
GB1478553A (en) Tetrapeptide amide and acid addition salts thereof
GB1161858A (en) Novel Phenylalanine Derivatives and a process for the Manufacture thereof.
GB1324423A (en) Salicylamide derivatives
GB1470749A (en) Preparation of n-alkenyl-2-aminomethyl-pyrrolidines
GB1226701A (https=)
GB1497689A (en) Method for producing n-(4-fluorophenyl)-2,3-dichloromaleimide
GB1422223A (en) Isothiocyanates

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee